AIA
REGN icon

Avalon Investment & Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Avalon Investment & Advisory’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$11.4M Buy
+13,831
New +$10.4M 0.31% 99
2021
Q2 		– Sell
-775
Closed -$367K – 367
2021
Q1 		$367K Sell
775
-739
-49% -$360K 0.01% 303
2020
Q4 		$731K Sell
1,514
-902
-37% -$487K 0.01% 273
2020
Q3 		$1.35M Buy
2,416
+182
+8% +$110K 0.03% 207
2020
Q2 		$1.39M Buy
2,234
+435
+24% +$247K 0.03% 200
2020
Q1 		$878K Sell
1,799
-51
-3% -$21K 0.02% 223
2019
Q4 		$695K Hold
1,850
– – 0.01% 255
2019
Q3 		$513K Sell
1,850
-58
-3% -$17.2K 0.01% 258
2019
Q2 		$597K Sell
1,908
-6
-0.3% -$2K 0.01% 266
2019
Q1 		$786K Sell
1,914
-100
-5% -$41.2K 0.02% 256
2018
Q4 		$752K Sell
2,014
-6
-0.3% -$2.2K 0.02% 250
2018
Q3 		$816K Hold
2,020
– – 0.02% 270
2018
Q2 		$697K Sell
2,020
-80
-4% -$25K 0.02% 279
2018
Q1 		$723K Sell
2,100
-17,760
-89% -$6.18M 0.02% 283
2017
Q4 		$7.47M Buy
19,860
+42
+0.2% +$17K 0.23% 134
2017
Q3 		$8.86M Buy
19,818
+98
+0.5% +$46.6K 0.28% 119
2017
Q2 		$9.69M Buy
+19,720
New +$8.63M 0.32% 105

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Avalon Investment & Advisory's REGN Position: Q1 2023 in Review

Avalon Investment & Advisory opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2023: 13,831 shares worth $11.4M. The stake represents 0.31% of the portfolio and ranks #99 among its holdings. This is a return to the name: Avalon Investment & Advisory previously reported a position in REGN as recently as Q1 2021.

Avalon Investment & Advisory first reported a position in REGN in Q2 2017 and has held it in 17 quarters since. 1,192 funds tracked by Wall St. Rank hold REGN as of Q1 2023.

  • Avalon Investment & Advisory held 13,831 shares of Regeneron Pharmaceuticals worth $11.4M as of Q1 2023.
  • Regeneron Pharmaceuticals was a new Avalon Investment & Advisory position in Q1 2023.
  • Regeneron Pharmaceuticals made up 0.31% of Avalon Investment & Advisory's portfolio in Q1 2023, its #99 holding.
  • Avalon Investment & Advisory first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 17 quarters since.
  • 1,192 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2023.

Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.